Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
Chhaparwal
M
M
Dept KEM Hospital, Bombay.
Saraf
M L
ML
D045930:Anabolic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*
D045930:Anabolic Agents; D009277:Nandrolone; D000077603:Nandrolone Decanoate